Ruthenium-based photoactivated chemotherapy against eye cancer

Project description

Photoactivated chemotherapy for the treatment of uveal melanoma

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• medical and health sciences › clinical medicine › oncology › skin cancer › melanoma
• medical and health sciences › clinical medicine › embryology

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) Main Programme

Topic(s)

• ERC-2019-POC - ERC Proof of Concept Grant

Call for proposal

ERC-2019-PoC

See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

UNIVERSITEIT LEIDEN

Net EU contribution

€ 150 000,00

Address

Rapenburg 70
2311 EZ Leiden
Netherlands

Region

West-Nederland › Zuid-Holland › Agglomeratie Leiden en Bollenstreek

Activity type

Higher or Secondary Education Establishments

Links

Non-EU contribution

No data

Beneficiaries (1)

UNIVERSITEIT LEIDEN

Netherlands

Net EU contribution

€ 150 000,00

Address

Rapenburg 70
2311 EZ Leiden

Region

West-Nederland › Zuid-Holland › Agglomeratie Leiden en Bollenstreek

Activity type

Higher or Secondary Education Establishments

Links

Non-EU contribution

No data